FBXL19 and Cirrhosis: The FBXL19-AS1 expression level was also evaluated through qPCR in plasma samples, which were taken from 79 healthy subjects, 77 patients with hepatitis B, 80 patients with cirrhosis, and 92 patients with HCC (Figure 4C).